搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia fergusonii ATP synthase gamma chain (atpG) CSB-YP483265EOR
CSB-EP483265EOR
CSB-BP483265EOR
CSB-MP483265EOR
CSB-EP483265EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Aspartate--ammonia ligase (asnA) CSB-YP483266EOR
CSB-EP483266EOR
CSB-BP483266EOR
CSB-MP483266EOR
CSB-EP483266EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Co-chaperone protein hscB (hscB) CSB-YP483267EOR
CSB-EP483267EOR
CSB-BP483267EOR
CSB-MP483267EOR
CSB-EP483267EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (ispG) CSB-YP483268EOR
CSB-EP483268EOR
CSB-BP483268EOR
CSB-MP483268EOR
CSB-EP483268EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii DnaA-homolog protein hda (hda) CSB-YP483269EOR
CSB-EP483269EOR
CSB-BP483269EOR
CSB-MP483269EOR
CSB-EP483269EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Succinyl-diaminopimelate desuccinylase (dapE) CSB-YP483270EOR
CSB-EP483270EOR
CSB-BP483270EOR
CSB-MP483270EOR
CSB-EP483270EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Quinolinate synthase A (nadA) CSB-YP483271EOR
CSB-EP483271EOR
CSB-BP483271EOR
CSB-MP483271EOR
CSB-EP483271EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB CSB-YP483272EOR
CSB-EP483272EOR
CSB-BP483272EOR
CSB-MP483272EOR
CSB-EP483272EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii UPF0250 protein ybeD (ybeD) CSB-YP483273EOR
CSB-EP483273EOR
CSB-BP483273EOR
CSB-MP483273EOR
CSB-EP483273EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Recombination protein RecR (recR) CSB-YP483274EOR
CSB-EP483274EOR
CSB-BP483274EOR
CSB-MP483274EOR
CSB-EP483274EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Fumarate reductase subunit C (frdC), partial CSB-YP483275EOR1
CSB-EP483275EOR1
CSB-BP483275EOR1
CSB-MP483275EOR1
CSB-EP483275EOR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Adenylosuccinate synthetase (purA) CSB-YP483276EOR
CSB-EP483276EOR
CSB-BP483276EOR
CSB-MP483276EOR
CSB-EP483276EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii NADH-quinone oxidoreductase subunit C/D (nuoC), partial CSB-YP483277EOR
CSB-EP483277EOR
CSB-BP483277EOR
CSB-MP483277EOR
CSB-EP483277EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnF (arnF), partial CSB-YP483278EOR1
CSB-EP483278EOR1
CSB-BP483278EOR1
CSB-MP483278EOR1
CSB-EP483278EOR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii N utilization substance protein B homolog (nusB) CSB-YP483279EOR
CSB-EP483279EOR
CSB-BP483279EOR
CSB-MP483279EOR
CSB-EP483279EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Recombination-associated protein rdgC (rdgC) CSB-YP483280EOR
CSB-EP483280EOR
CSB-BP483280EOR
CSB-MP483280EOR
CSB-EP483280EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Aspartate carbamoyltransferase (pyrB) CSB-YP483281EOR
CSB-EP483281EOR
CSB-BP483281EOR
CSB-MP483281EOR
CSB-EP483281EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii 5-keto-4-deoxy-D-glucarate aldolase (garL) CSB-YP483282EOR
CSB-EP483282EOR
CSB-BP483282EOR
CSB-MP483282EOR
CSB-EP483282EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Hydroxylamine reductase (hcp), partial CSB-YP483283EOR
CSB-EP483283EOR
CSB-BP483283EOR
CSB-MP483283EOR
CSB-EP483283EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia fergusonii Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP483284EOR
CSB-EP483284EOR
CSB-BP483284EOR
CSB-MP483284EOR
CSB-EP483284EOR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>